Abstract:Objective Human telomerase reverse transcriptase(hTERT),widely present in human cancers,generally absent in normal tissues,and required for tumor cell survival,is essentially identified as an almost ideal universal tumor associated antigen.As HLA-A*0201-expressing individuals constitute more than 30% of the Chinese population,to identify peptides derived from hTERT HLA-A*0201-restricted CTL epitopes is of great clinical significance for specific immunotherapy against tumor.The present study was to predict and identify hTERT specific HLA-A*0201 restricted epitopes using bioinformatic methods and immunological assay.Methods The online databases SYFPEITHI,BIMAS and NetCTL and molecular modeling were applied to predict the potential HLA-A*0201 restricted epitopes from hTERT.T2 cells were used to determine the peptide binding affinity and HLA-A*0201 peptide complex stability.IFN-γ ELISPOT was employed to monitor the magnitude of specific T lymphocytes to candidate peptides.Results We obtained 6 epitopes with high immunogenicity scores,i.e.,ILAKFLHWL(540-548),LMSVYVVEL(548-556),ILSTLLCSL(836-844),CLKELVARV(76-84),LLGASVLGL(675-683),and FLDLQVNSL(923-931),of which,2 satisfied the criteria of HLA-A*0201-restricted CTL epitopes in molecular modeling analysis.ILAKFLHWL(540-548) and ILLGASVLGL(675-683) could bind to HLA-A*0201 with high affinity and flurorescene indexes(FI) of 3.20 and 2.98,respectively,and the dissociation time of 50% HLA-A*0201 peptide complex was 8 h.ELISPOT analysis showed that ILLGASVLGL(675-683) could induce T lymphocyte responses.The frequency of peptide-specific T cells was 534±57 SFC/106 PBMCs.Conclusion ILLGASVLGL(675-683) might be a new HLA-A*0201 restricted CTL epitope.

Molecular Field Analysis on HLA-A*0201 Restricted CTL Epitope

3D-Qsar Study on the Hla-A*0201 Restricted Ctl Epitope

Identification of predicted epitopes of HLA-A * 0201-restricted cytotoxic T lymphocytes derived from human papillomavirus type 11 E7 antigen

A Novel Method to Estimate the Affinity of HLA-A∗0201 Restricted CTL Epitope

Estimation of affinity of HLA-A*0201 restricted CTL epitope based on the SCORE function.

Prediction of HLA-A*0201 Restricted Cytotoxic T Lymphocyte Epitopes Based on High-Dimensional Descriptor Nonlinear Screening

A Rapid Method for Quantitative Prediction of High Affinity CTL Epitopes: QSAR Studies on Peptides Having Affinity with the Class I MHC Molecular HLA-A*0201

Estimation of the Affinity of HLA-A*0201 Restricted CTL Epitope Based on SCORE Function

A Structure‐based, Quantitative Structure–Activity Relationship Approach for Predicting HLA‐A*0201‐restricted Cytotoxic T Lymphocyte Epitopes

Study On Quantitative Structure-Activity Relationships Of Hla-A*0201 Restrictive Ctl Epitopes

A New Set of Amino Acid Descriptors for the Development of Quantitative Sequence‐Activity Modelings of HLA‐A*0201 Restrictive CTL Epitopes

Prediction and Identification of HLA-A2 Restricted CTL Epitope Derived from the Leukemia-Associated Antigen MLAA-34

Toward the Quantitative Prediction of T-Cell Epitopes: QSAR Studies on Peptides Having Affinity with the Class I MHC Molecular HLA-A*0201.

Screening of HLA-A2 Restricted CTL Epitopes Using Molecular Simulation

Prediction and Peptide Binding Analysis of HLA-A*0201-restricted CTL Epitope from MUC4

Applying Generalized Hydrophobicity Scale of Amino Acids to Quantitative Prediction of Human Leukocyte Antigen-A*0201-restricted Cytotoxic T Lymphocyte Epitope

In Silico Quantitative Prediction of Peptides Binding Affinity to Human MHC Molecule: an Intuitive Quantitative Structure–activity Relationship Approach

Prediction and Identification of HLA-A*0201-restricted Epitopes from Leukemia-Associated Protein MLAA-22 Which Elicit Cytotoxic T Lymphocytes

Prediction of HLA-A2.1 Restricted CTL Epitope of SSX Gene Family and Affinity Assay of These Epitopes with MHC- Ⅰ Molecule

Identification of a new HLA-A*0201-restricted cytotoxic T lymphocyte epitope from CML28

Prediction and Identification of HLA-A * 0201-Restricted CTL Epitopes from Htert